Table 3.
|
|
|
|
|
|
Clinical stage |
|
|
|
|
|
|
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Authors | Year of publication | Patients (N) | Surgical volume | Mean/median age (year) | Preop PSA (ng/mL) | T1c | T2 | Operative time (min) | Mean EBL (mL) | % Transfused | Open conversion (%) | Hospital length of stay (days) | Complication rate (%) |
Hu43 | 2006 | 322 | 297 RPs/ya | 62.1 | - | 74.50 | 24.80 | 186 | 250 | 1.60 | 0 | - | 14.60 |
Joseph48 | 2006 | 325 | 162 RARPs/y | 60 | 6.6 | 81.00 | 19.00 | 130 | 196 | 1.30 | 0.00 | - | 8.60 |
Badani49 | 2007 | 2766 | 461 RARPs/y | 60.2 | 6.4 | 77.30 | 22.00 | 154 | 142 | 1.50 | 0.10 | 1.14 | 12.20 |
Nelson28 | 2007 | 629 | 334 RPs/yb | 59.3 | 6.4 | - | - | - | - | - | - | 1.17 | 17 |
Borin50 | 2007 | 400 | c | 61.2 | 6.6 | 68 | 26.5 | - | 103.5 | - | - | 1 | - |
Zorn51 | 2007 | 744 | 233 RARPs/y | 59.6 | 6.6 | 74 | 26 | 234 | 222 | 1.20 | 1.20 | 1.2 | - |
Schroeck30 | 2008 | 362 | 234 RPs/y | 59.2 | 5.4 | 83.10 | 16.90 | - | 150 | - | 1.60 | - | - |
Chan31 | 2008 | 660 | 220RARPs/y | 60 | 6.8 | 75.30 | 24.70 | 207 | 140 | 0.80 | 0.90 | 1.3 | - |
Patel52 | 2008 | 1500 | c | 61 | 6.1 | 78 | 20 | 105 | 111 | 0.50 | 0 | 1.1 | 4.30 |
Krambeck35 | 2009 | 294 | 120 RARPs/y | 61 | 4.9 | 72.8 | 26.9 | 236 | - | 5.1 | - | - | 8 |
Murphy53 | 2009 | 400 | 154 RARPs/y | 60.2 | 7 | 69.70 | 30.30 | 186 | - | 2.5 | 0.30 | 3.1 | 15.70 |
Ham54 | 2009 | 321 | 137 RARPs/y | 63.5 | 29.7 | - | - | 219 | 402 | - | - | 5.3 | 5.3 |
Weighted means | 60.4 | 7.23 | 76.2 | 22.8 | 162.6 | 164.2 | 1.4 | 0.34 | 1.43 | 10.3 |
Total number of RPs included in the comparative study per year (LRP and RARP combined).
Total number of RPs included in the comparative study per year (RRP and RARP combined).
c = time frame of the study not reported; Preop = preoperative; PSA = prostate-specific antigen; EBL = estimated blood loss; RP = radical prostatectomy; RARP = robot-assisted radical prostatectomy.